Formulation Advances in Posterior Segment Ocular Drug Delivery
Journal of Ocular Pharmacology and Therapeutics · 2025
DOI: 10.1089/jop.2024.0153 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Tumpa Sarkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India. Hauptthemen laut MEDLINE: Drug Delivery Systems, Posterior Eye Segment, Eye Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 254 Literaturangaben.
Abstract (Originalsprache)
Posterior segment ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion, are leading causes of vision impairment and blindness worldwide. Effective management of these conditions remains a formidable challenge due to the unique anatomical and physiological barriers of the eye, including the blood–retinal barrier and rapid drug clearance mechanisms. To address these hurdles, nanostructured drug delivery systems are proposed to overcome ocular barriers, target the retina, and enhance permeation while ensuring controlled release. Traditional therapeutic approaches, such as intravitreal injections, pose significant drawbacks, including patient discomfort, poor compliance, and potential complications. Therefore, understanding the physiology and clearance mechanism of eye could aid in the design of novel formulations that could be noninvasive and deliver drugs to reach the target site is pivotal for effective treatment strategies. This review focuses on recent advances in formulation strategies for posterior segment ocular drug delivery, highlighting their potential to overcome these limitations. Furthermore, the potential of nanocarrier systems such as in-situ gel, niosomes, hydrogels, dendrimers, liposomes, nanoparticles, and nanoemulsions for drug delivery more effectively and selectively is explored, and supplemented with illustrative examples, figures, and tables. This review aims to provide insights into the current state of posterior segment drug delivery, emphasizing the need for interdisciplinary approaches to develop patient-centric, minimally invasive, and effective therapeutic solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
Zitieren
APA
Sarkar, T., Gogoi, N. R., Jana, B. K., & Mazumder, B. (2025). Formulation Advances in Posterior Segment Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0153
Vancouver
Sarkar T, Gogoi NR, Jana BK, Mazumder B. Formulation Advances in Posterior Segment Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2024.0153
BibTeX
@article{Sarkar2025,
author = {Sarkar, Tumpa and Gogoi, Niva Rani and Jana, Bani Kumar and Mazumder, Bhaskar},
title = {Formulation Advances in Posterior Segment Ocular Drug Delivery},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2025},
doi = {10.1089/jop.2024.0153}
}
EUVIMED